Savara, Inc. (SVRA)
4.76
+0.13
(+2.81%)
USD |
NASDAQ |
Oct 20, 16:00
4.99
+0.23
(+4.83%)
After-Hours: 07:17
Savara Gross Profit (TTM) : -0.281M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.281M |
| March 31, 2026 | -0.256M |
| December 31, 2025 | -0.258M |
| September 30, 2025 | -0.288M |
| June 30, 2025 | -0.281M |
| March 31, 2025 | -0.276M |
| December 31, 2024 | -0.275M |
| September 30, 2024 | -0.271M |
| June 30, 2024 | -0.265M |
| March 31, 2024 | -0.22M |
| December 31, 2023 | -0.176M |
| September 30, 2023 | -0.152M |
| June 30, 2023 | -0.132M |
| March 31, 2023 | -0.149M |
| December 31, 2022 | -0.167M |
| September 30, 2022 | -0.262M |
| June 30, 2022 | -0.239M |
| March 31, 2022 | -0.304M |
| December 31, 2021 | -0.367M |
| September 30, 2021 | -0.23M |
| June 30, 2021 | -0.21M |
| March 31, 2021 | -0.317M |
| December 31, 2020 | -0.455M |
| September 30, 2020 | -0.693M |
| June 30, 2020 | -0.926M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.945M |
| December 31, 2019 | -1.01M |
| September 30, 2019 | -0.911M |
| June 30, 2019 | -0.805M |
| March 31, 2019 | -0.726M |
| December 31, 2018 | -0.526M |
| September 30, 2018 | -0.478M |
| June 30, 2018 | -0.442M |
| March 31, 2018 | -0.38M |
| December 31, 2017 | -0.363M |
| September 30, 2017 | -0.272M |
| June 30, 2017 | -0.267M |
| March 31, 2017 | -0.261M |
| December 31, 2016 | -0.203M |
| September 30, 2016 | -0.244M |
| June 30, 2016 | -0.196M |
| March 31, 2016 | -0.148M |
| December 31, 2015 | -0.146M |
| September 30, 2015 | -0.1302M |
| June 30, 2015 | -0.118M |
| March 31, 2015 | -0.1036M |
| December 31, 2014 | -0.085M |
| September 30, 2014 | -0.0705M |
| June 30, 2014 | -0.0548M |
| March 31, 2014 | -0.0412M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Gilead Sciences, Inc. | 24.33B |
| Insmed, Inc. | 941.78M |
| United Therapeutics Corp. | 2.717B |
| Vertex Pharmaceuticals, Inc. | 10.94B |
| ACADIA Pharmaceuticals, Inc. | 1.038B |